Water without these coliphages is considered pathogen-free, and more importantly, safe drinking water.
Water without these coliphages is considered pathogen-free, and more importantly, safe drinking water.
“We aim to positively contribute to the global water crisis, and now, in 2021, we are proud to have achieved B-Corporation status, recognizing and reinforcing our mission to provide Safe Water for a Better World”
Enric Queralt
Bluephage CEO
We are developers of the quickest, most accurate and easy-to-use method for the analysis of faecal and viral contamination in water
In a world where more than 2.5 billion people do not have access to safe drinking water, and a trend to reuse more water worldwide, Bluephage’s mission is to increase and improve the microbiological monitoring of water through viral indicators by providing easy-to-use, fast, simple, reliable and cost-effective kits to test for coliphages, thus ensuring safe water for a better world. Join the Bluephage revolution!
We are developers of the quickest, most accurate and easy-to-use method for the analysis of faecal and viral contamination in water
In a world where more than 2.5 billion people do not have access to safe drinking water, and a trend to reuse more water worldwide, Bluephage’s mission is to increase and improve the microbiological monitoring of water through viral indicators by providing easy-to-use, fast, simple, reliable and cost-effective kits to test for coliphages, thus ensuring safe water for a better world. Join the Bluephage revolution!
be part of our vision
Safe water for a better world
be part of our vision
Safe water for a better world
The quickest, most accurate and easy-to-use viral indicator tests available for microbial water quality assessment
MAIN CHARACTERISTICS
quick results
< 6’5 hours
equivalence
To ISO and US-EPA standard methods
easy-to-use
Basic laboratory equipment
high sensitivity
Low limit of 1pfu/100 mL
easy storage
Biological material at -20ºC
Rest of components at Room Temperature
effective test results
Presence/Absence
Quantitative
Bluephage solution
Bluephage now offers an innovative and patented technology that allows rapid, easy, and cost-effective detection and enumeration of coliphages in one working day versus the time required by standardized methods.
Discover Bluephage’s portfolio of products and simplify and accelerate the coliphage enumeration process in water analysis.
The quickest, most accurate and easy-to-use viral indicator tests available for microbial water quality assessment
MAIN CHARACTERISTICS
Bluephage solution
Bluephage now offers an innovative and patented technology that allows rapid, easy, and cost-effective detection and enumeration of coliphages in one working day versus the time required by standardized methods.
Discover Bluephage’s portfolio of products and simplify and accelerate the coliphage enumeration process in water analysis.
quick results
< 6’5 hours
easy-to-use
Basic laboratory equipment
easy storage
Biological material at -20ºC
Rest of components at Room Temperature
equivalence
To ISO and US-EPA standard methods
high sensitivity
Low limit of 1pfu/100 mL
effective test results
Presence/Absence
Quantitative
a new approach for water testing
Why Coliphages
billion people
without access to
safe drinking water
disease
associated with
contaminated water worldwide
million hospitalizations
a year in developed countries
due to waterborne pathogens
“The World Health Organization, the US-EPA, and the European Commission have recently recognized the coliphage test as a new viral indicator. The presence of coliphages equals tainted water; the absence of coliphages means safe water. This is because bacterial indicators, still widely used, have significant limitations and inefficiencies, especially when looking at viral pathogens in water.”
Anicet R. Blanch
Bluephage CTO and Co-Founder
blog and news
Greater social awareness is needed to invest in innovative and sustainable technologies to treat human-generated waste, including water.
Bluephage promotes the sustainability of the water cycle by ensuring the microbiological safety of wastewater.
WHO warns on AMR to be one of the top 10 threats to global public health
Bluephage’s technology solutions can help prevent waterborne diseases.
Bluephage successfully closes its crowdfunding round beating its initial goal by 114% and raising €916,714 in just one month.
The entire Bluephage team would like to thank all of the more than 602 investors who believe in the Rapid Kit test for the analysis of coliphages,
member of
incubated by
Sponsored by CDTI
Part of this project has been financed by the general budgets of the spanish state in charge of the application 27.12.467C.74908
